0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover0.00%IV-57.23%PremiumJul 19, 2024Expiry Date3.64Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Relay Therapeutics Stock Discussion
Relay Therapeutics Announces Clinical Trial Collaboration With Pfizer to Evaluate Atirmociclib in Combination With Rly-2608
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...
Oppenheimer strategist John Stoltzfus has outlined 10 predictions for the transformative impact of generative AI across various industries. The key focus of generative AI lies in its revolutionary potential to create entirely novel designs and products that may surpass human imagination.
1. Healthcare Augm...
this stock got a whole discount sale rn, put in while its low and u gon make some REAL bread
ALERT ON: $18.07
ON THE ⌚: $18.23
🥇 SIGNED OF MORE UPTREND - $18.36
NEED IT TO BREAK OVER: $18.47
🗝️ indicator for MORE uptrend $18.54
confirmation uptrend - $18.63
mini breakout - $18.88. $Relay Therapeutics(RLAY.US)$
No comment yet